Table 1.
Sociodemographic characteristics of single users per month, pooled before and during the pandemic (2016–2022).
| All (n = 21,281,128) | SIS (n = 20,313,146) | EPS (n = 1,041,537) | FISSAL (n = 326,098) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | ||
| Sex | Female | 11,517,384 | 54.1% | 11,039,051 | 54.3% | 512,648 | 49.2% | 201,132 | 61.7% |
| Male | 9,763,744 | 45.9% | 9,274,095 | 45.7% | 528,889 | 50.8% | 124,966 | 38.3% | |
| Age group | 0–11 | 6,613,849 | 31.1% | 6,414,147 | 31.6% | 217,274 | 20.9% | 24,757 | 7.6% |
| 12–17 | 2,122,957 | 10.0% | 2,058,859 | 10.1% | 69,552 | 6.7% | 8727 | 2.7% | |
| 18–64 | 10,965,666 | 51.5% | 10,296,584 | 50.7% | 719,160 | 69.0% | 186,311 | 57.1% | |
| 65 or more | 1,578,656 | 7.4% | 1,543,556 | 7.6% | 35,551 | 3.4% | 106,303 | 32.6% | |
| Wealth quartile | Q1 | 5,539,129 | 26.0% | 5,531,139 | 27.2% | 10,452 | 1.0% | 35,936 | 11.0% |
| Q2 | 4,548,038 | 21.4% | 4,502,281 | 22.2% | 53,460 | 5.1% | 54,683 | 16.8% | |
| Q3 | 3,804,676 | 17.9% | 3,659,220 | 18.0% | 162,816 | 15.6% | 78,266 | 24.0% | |
| Q4 | 3,688,104 | 17.3% | 3,495,267 | 17.2% | 210,867 | 20.2% | 82,616 | 25.3% | |
| Q5 | 3,701,181 | 17.4% | 3,125,239 | 15.4% | 603,942 | 58.0% | 74,597 | 22.9% | |
| Pandemic* | Before | 16,869,327 | 79.3% | 16,011,798 | 78.8% | 923,116 | 88.6% | 278,757 | 85.5% |
| During | 15,750,626 | 74.0% | 15,002,322 | 73.9% | 817,714 | 78.5% | 265,627 | 81.5% | |
| Health system* | SIS | 20,313,146 | 95.5% | 20,313,146 | 100.0% | 75,836 | 7.3% | 323,812 | 99.3% |
| EPS | 1,041,537 | 4.9% | 75,836 | 0.4% | 1,041,537 | 100.0% | 999 | 0.3% | |
| FISSAL | 326,098 | 1.5% | 323,812 | 1.6% | 999 | 0.1% | 326,098 | 100.0% | |
| Charlson’s classification* | Others | 21,247,086 | 99.8% | 20,282,496 | 99.8% | 1,040,421 | 99.9% | 321,940 | 98.7% |
| Cancer | 624,948 | 2.9% | 610,016 | 3.0% | 14,539 | 1.4% | 158,425 | 48.6% | |
| Metastatic carcinoma | 56,104 | 0.3% | 54,912 | 0.3% | 1365 | 0.1% | 27,624 | 8.5% | |
| Dementia | 37,717 | 0.2% | 35,804 | 0.2% | 2029 | 0.2% | 4956 | 1.5% | |
| Diabetes with complications | 211,689 | 1.0% | 200,105 | 1.0% | 12,449 | 1.2% | 56,719 | 17.4% | |
| Diabetes without complications | 1,402,344 | 6.6% | 1,333,632 | 6.6% | 74,735 | 7.2% | 134,405 | 41.2% | |
| Cerebrovascular disease | 187,407 | 0.9% | 167,681 | 0.8% | 20,761 | 2.0% | 24,326 | 7.5% | |
| Mild liver disease | 327,339 | 1.5% | 297,491 | 1.5% | 31,589 | 3.0% | 38,527 | 11.8% | |
| Moderate or severe liver disease | 39,612 | 0.2% | 38,605 | 0.2% | 1118 | 0.1% | 6172 | 1.9% | |
| Chronic pulmonary disease | 1,373,631 | 6.5% | 1,195,715 | 5.9% | 190,080 | 18.2% | 60,875 | 18.7% | |
| Kidney disease | 188,812 | 0.9% | 181,427 | 0.9% | 7854 | 0.8% | 80,438 | 24.7% | |
| Rheumatic and connective tissue diseases | 330,849 | 1.6% | 311,557 | 1.5% | 20,590 | 2.0% | 28,386 | 8.7% | |
| Peptic ulcer disease | 120,284 | 0.6% | 108,878 | 0.5% | 12,131 | 1.2% | 11,001 | 3.4% | |
| Peripheral vascular disease | 25,383 | 0.1% | 22,315 | 0.1% | 3183 | 0.3% | 5291 | 1.6% | |
| Myocardial infarction | 37,417 | 0.2% | 35,246 | 0.2% | 2391 | 0.2% | 6098 | 1.9% | |
| Congestive heart failure | 173,053 | 0.8% | 162,330 | 0.8% | 11,307 | 1.1% | 33,459 | 10.3% | |
| Paraplegia and hemiplegia | 40,388 | 0.2% | 38,635 | 0.2% | 1916 | 0.2% | 6348 | 1.9% | |
| HIV AIDS | 157,771 | 0.7% | 156,896 | 0.8% | 1560 | 0.1% | 7705 | 2.4% | |
SIS comprehensive health insurance (in Spanish), EPS private healthcare entities (in Spanish), FISSAL intangible solidarity health fund (in Spanish).
*Values do not add up to 100%.